Search

Your search keyword '"Gardini, Andrea Casadei"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Gardini, Andrea Casadei" Remove constraint Author: "Gardini, Andrea Casadei" Journal journal of hepatology Remove constraint Journal: journal of hepatology
19 results on '"Gardini, Andrea Casadei"'

Search Results

1. Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments

2. Deep learning predicts sensitivity to atezolizumab-bevacizumab from digital slides of hepatocellular carcinoma

3. Incidence and risk factors of esophagogastric varices bleeding in patients with advanced hepatocellular carcinoma treated with lenvatinib

5. The genomic landscape of IDH1 mutant intrahepatic cholangiocarcinoma: a multicentre comprehensive analysis

6. Proteomic analysis of bile in the rat thioacetamide model reveals new mechanisms in human cholangiocarcinogenesis

7. Plasma cell-free DNA methylation as biomarker for hepatocellular carcinoma

8. THU-145 - Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments

9. THU-131 - Incidence and risk factors of esophagogastric varices bleeding in patients with advanced hepatocellular carcinoma treated with lenvatinib

11. LBO-04 - Deep learning predicts sensitivity to atezolizumab-bevacizumab from digital slides of hepatocellular carcinoma

12. SAT180 - The genomic landscape of IDH1 mutant intrahepatic cholangiocarcinoma: a multicentre comprehensive analysis

13. FRI554 - Proteomic analysis of bile in the rat thioacetamide model reveals new mechanisms in human cholangiocarcinogenesis

14. FRI222 - Plasma cell-free DNA methylation as biomarker for hepatocellular carcinoma

16. THU-448-Multicentric prospettive study of validation of angiogenesis-related gene polymorphisms in hepatocellular carcinoma patients treated with sorafenib: Interim analysis of INNOVATE study

17. PS-043-Dual targeting of G9a and DNM-methyltransferase-1 for the treatment of experimental cholangiocarcinoma

19. FRI-474-AGT gene polymorphisms predict early dose modification of sorafenib for dermatological adverse events: towards tailored medicine for patients with hepatocellular carcinoma

Catalog

Books, media, physical & digital resources